Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a nasal cannula beat a mask for chest trauma breathing support?

NCT ID NCT05828030

Symptom relief Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares two breathing support methods for people with chest trauma who have low oxygen levels. One group gets a high flow nasal cannula, the other a standard oxygen mask. The goal is to see if the nasal cannula reduces the need for a breathing tube or pneumonia. About 100 participants will be enrolled.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
high flow nasal cannula
What this could lead to
If it works, this could offer a more comfortable and effective way to support breathing in chest trauma patients, potentially reducing the need for a breathing tube.
What could go wrong
This is a small, early-stage study with only 100 participants, so results may not apply to all patients. The intervention is a procedure, not a drug, so benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2023

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients who have the following condition within 72 hours of chest trauma despite receiving standard nasal cannula oxygen therapy \[≥10 L/min\], are eligible for inclusion. * severe hypoxemic respiratory failure \[Arterial partial pressure of oxygen (PaO2)/fraction of inspired oxygen fraction(FiO2) \<300 mmHg\] * with a respiratory rate \>25 breaths/minute and difficulty breathing, or respiratory distress * PaCO2 of 45 mmHg or higher (if the patient requires emergency surgery with endotracheal intubation and mechanical ventilation, the time of inclusion will be the start of the post-extubation period. (Note: For patients who receive emergency trauma surgery with endotracheal intubation and mechanical ventilation, the time of inclusion assessment will be 72 hours after extubation.) Exclusion Criteria: 1. Patients with a Glasgow Coma Scale less than 8 or severe brain injury. 2. Patients with any contraindications to non-invasive ventilation, including acute gastrointestinal bleeding, upper airway obstruction, or hemodynamic instability. 3. Facial trauma involving skull base fractures, facial bone fractures, or orbital floor fractures. 4. Severe injuries involving the nasal sinuses. 5. Patients with cervical spine injuries. 6. Patients with increased intracranial pressure. 7. Patients with facial, nasal, or airway structural abnormalities or surgery that prevents the use of appropriate nasal cannula. 8. Patients after upper airway surgery. 9. Patients who are unable to clearly express their willingness to sign informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chest trauma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hypoxia injury Thoracic Injuries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chest trauma Hypoxia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Traumatology, National Taiwain University Hospital

    RECRUITING

    Taipei, Taipei, 10002, Taiwan

  • NTUH Hsin-Chu Branch; NTUH Yun-Lin Branch

    RECRUITING

    Taipei, Taiwan, 100; 300; 640; 280, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.